Stock events for Waystar Holding Corp. (WAY)
In August 2025, Waystar reported strong Q2 results but the stock fell after the earnings call. The company announced the repricing of its first lien term loan and completed the acquisition of Iodine Software. In December 2025, Waystar's stock declined, hitting a 52-week low, and the company presented at the J.P. Morgan Healthcare Conference. In January 2026, Waystar introduced Agentic AI, and Chief Business Officer Eric Sinclair III sold shares of common stock. In February 2026, Waystar announced the resignation of its Chief Business Officer and is scheduled to announce its Fourth Quarter and Fiscal Year 2025 financial results. Overall, the stock has experienced a decline of approximately 40% over the last 12 months.
Demand Seasonality affecting Waystar Holding Corp.’s stock price
While specific detailed information on demand seasonality for all Waystar products and services is not extensively provided, there is an indication of seasonality in patient payments. Waystar's Q4 2024 results exceeded analyst expectations, partly driven by "higher-than-seasonal patient payments," suggesting that patient payment volumes may experience fluctuations throughout the year, with a potential increase in the fourth quarter.
Overview of Waystar Holding Corp.’s business
Waystar Holding Corp. is a healthcare technology company that provides cloud-based software solutions to simplify healthcare payments. Formed in November 2017 through the merger of Navicure and Zirmed, the company offers a comprehensive suite of solutions, including financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting. Waystar leverages AI and proprietary advanced algorithms to automate payment-related workflow tasks, enhancing claim and billing accuracy, enriching data integrity, and reducing labor costs for providers.
WAY’s Geographic footprint
Waystar Holding Corp. primarily serves the healthcare industry throughout the United States, including Puerto Rico and other U.S. Territories. As of October 2023, Waystar served over 3,000 healthcare organizations across the United States, Canada, and Europe. The company serves over 30,000 clients, representing over 1 million distinct providers, including 16 of the top 20 institutions on the U.S. News Best Hospitals list. Its platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims, spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges.
WAY Corporate Image Assessment
Waystar Holding Corp. maintains a strong brand reputation within the healthcare technology sector. The company has consistently received positive recognition, including "Best in KLAS for Patient Access" and "continued Best in KLAS honors" for over a decade. Clients express high satisfaction, and the company is recognized as a trusted partner in healthcare technology. One event that could have potentially affected its reputation was the revocation of its Exchange Act registration as a Municipal Advisor. However, the overall sentiment in recent reports remains largely positive.
Ownership
Waystar Holding Corp. has a significant institutional ownership structure. Major institutional shareholders include EQT Fund Management S.a r.l., Canada Pension Plan Investment Board, BlackRock, Inc., Bain Capital, LP, The Vanguard Group, Inc., and Advent International, L.P. Institutional investors collectively hold a substantial portion of the company's shares, while individual ownership accounts for approximately 2.5% of the shares.
Ask Our Expert AI Analyst
Price Chart
$25.65